Related Experiment Videos

The treatment of hemangiomas: with special reference to the role of steroid therapy

Annals of Surgery
|May 1, 1976
PubMed

Insights

This review details 25 years of experience managing over 1000 patients with vascular anomalies, including hemangiomas. High-dose Prednisone is highlighted as a key treatment for juvenile capillary hemangiomas.

Area of Science:

  • Vascular Surgery
  • Pediatric Dermatology
  • Medical Genetics

Background:

  • Hemangiomas are the most common congenital anomaly.
  • Developmental vascular anomalies encompass a wide spectrum of conditions.
  • Accurate classification is crucial for prognosis and treatment planning.

Purpose of the Study:

  • To present a 25-year clinical experience with over 1000 patients.
  • To propose a useful clinical classification for vascular anomalies.
  • To evaluate various treatment modalities for hemangiomas and related disorders.

Main Methods:

  • Review of a 25-year personal experience with over 1000 patients.
  • Analysis of treatment outcomes for surgical excision, irradiation, CO2 freezing, sclerosing agents, cauterization, steroid therapy, and watchful waiting.
  • Evaluation of high-dose, short-course Prednisone therapy for juvenile capillary hemangiomas.

Main Results:

  • A new clinical classification is proposed to aid in prognosis and therapeutic decisions.
  • High-dose, short-course Prednisone therapy demonstrated significant success in treating massive juvenile capillary hemangiomas.
  • Several treatment modalities showed disappointing results, while others were effective.

Conclusions:

  • A refined classification system improves management of vascular anomalies.
  • Prednisone therapy represents a significant advancement for specific hemangioma types.
  • Understanding growth, resolution, and etiology is vital for surgical approaches.

Related Concept Videos